Toward rapamycin analog (rapalog)-based precision cancer therapy
about
Present Advances and Future Perspectives of Molecular Targeted Therapy for OsteosarcomaA synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancersSynergistic antitumor activity of the combination of salubrinal and rapamycin against human cholangiocarcinoma cells.Nutritional strategies to optimise cognitive function in the aging brain.Recent advances in targeting mTOR signaling pathway using small molecule inhibitors.Emerging Role of MicroRNAs in mTOR Signaling.DEPDC5 as a potential therapeutic target for epilepsy.CENPH Inhibits Rapamycin Sensitivity by Regulating GOLPH3-dependent mTOR Signaling Pathway in Colorectal Cancer.Rab1 GTPases as oncogenes.Precision cancer medicine: where to target?Outside-in HLA class I signaling regulates ICAM-1 clustering and endothelial cell-monocyte interactions via mTOR in transplant antibody-mediated rejection.Immunohistochemical evaluation of the mTOR pathway in intra-oral minor salivary gland neoplasms.mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model.Cancer; an induced disease of twentieth century! Induction of tolerance, increased entropy and 'Dark Energy': loss of biorhythms (Anabolism v. Catabolism).Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases
P2860
Q26750631-28D6BBCD-6A7D-4EE0-B12C-6CB6D495DEA1Q35925179-685F3736-D28E-4621-97FC-DEA577EA26F5Q37709171-003AD08B-7B6B-4995-9796-CEC3DB9D325CQ38880656-B3FC042E-D6F7-4C20-AB29-C17B5A39EC6BQ38955246-4C5BB036-D738-42AC-A506-371AE9C298CBQ39151248-5EA208EE-9B03-47F4-953C-7B3F56D13C90Q39239920-0B88B966-EE1F-4598-9951-428CD0A0130AQ41440959-46E769A4-1989-4659-854D-F8AC388FF246Q41583387-20E156CB-5531-4718-B067-68E0BCA455E1Q43170563-0121DC74-3CB1-49B1-BD8E-75EE53DD60BDQ46258296-8BDB6522-451C-4471-A6FB-E64204BFD84AQ54194644-E2C495B1-053A-4A18-B80F-D6CA0794E37BQ54978861-E2858131-A4A1-4AF4-92DE-6BB902DB76A7Q55709806-6AA5160F-01AC-4C6E-BA69-F59025152BC0Q57300947-DE574019-866D-4231-8F2C-61026CAFF448
P2860
Toward rapamycin analog (rapalog)-based precision cancer therapy
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Toward rapamycin analog (rapalog)-based precision cancer therapy
@ast
Toward rapamycin analog (rapalog)-based precision cancer therapy
@en
Toward rapamycin analog (rapalog)-based precision cancer therapy
@nl
type
label
Toward rapamycin analog (rapalog)-based precision cancer therapy
@ast
Toward rapamycin analog (rapalog)-based precision cancer therapy
@en
Toward rapamycin analog (rapalog)-based precision cancer therapy
@nl
prefLabel
Toward rapamycin analog (rapalog)-based precision cancer therapy
@ast
Toward rapamycin analog (rapalog)-based precision cancer therapy
@en
Toward rapamycin analog (rapalog)-based precision cancer therapy
@nl
P2860
P3181
P356
P1476
Toward rapamycin analog (rapalog)-based precision cancer therapy
@en
P2093
Ling-hua Meng
X F Steven Zheng
P2860
P2888
P304
P3181
P356
10.1038/APS.2015.68
P407
P577
2015-10-01T00:00:00Z
P5875
P6179
1027345358